Emmaus Life Sciences, Inc.
EMMA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $703 | $830 | $1,092 | $543 |
| - Cash | $293 | $886 | $1,333 | $1,389 |
| + Debt | $31,686 | $32,392 | $32,977 | $32,963 |
| Enterprise Value | $32,096 | $32,336 | $32,736 | $32,117 |
| Revenue | $3,378 | $2,817 | $2,406 | $3,292 |
| % Growth | 19.9% | 17.1% | -26.9% | – |
| Gross Profit | $3,131 | $2,667 | $2,181 | $2,983 |
| % Margin | 92.7% | 94.7% | 90.6% | 90.6% |
| EBITDA | $449 | -$43 | -$1,065 | -$459 |
| % Margin | 13.3% | -1.5% | -44.3% | -13.9% |
| Net Income | -$2,076 | -$1,135 | -$2,330 | -$1,748 |
| % Margin | -61.5% | -40.3% | -96.8% | -53.1% |
| EPS Diluted | -0.03 | -0.018 | -0.037 | -0.027 |
| % Growth | -68.5% | 51.2% | -33.2% | – |
| Operating Cash Flow | $409 | -$2,908 | $279 | $343 |
| Capital Expenditures | $0 | -$1 | $0 | -$6 |
| Free Cash Flow | $409 | -$2,909 | $279 | $337 |